Thu, February 9, 2023
[ 12:00 AM ] - WOPRAI
Thu, February 2, 2023
Thu, December 22, 2022
[ 12:00 AM ] - WOPRAI
Tue, October 12, 2021
[ 12:00 AM ] - WOPRAI
Thu, September 23, 2021
[ 12:00 AM ] - WOPRAI
Thu, July 1, 2021
Tue, June 15, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 11, 2020
[ 12:00 AM ] - WOPRAI
Fri, December 13, 2019
[ 12:00 AM ] - WOPRAI
Tue, August 20, 2019
[ 12:00 AM ] - WOPRAI
Fri, June 15, 2018
[ 12:00 AM ] - WOPRAI
Thu, January 4, 2018
[ 12:00 AM ] - WOPRAI
Mon, September 19, 2016
Wed, April 20, 2016
Tue, November 12, 2013
[ 12:00 AM ] - WOPRAI
Tue, April 16, 2013
Yun Zhong Maintained (AVXL) at Strong Buy with Decreased Target to $28 on, Feb 9th, 2023
Yun Zhong of BTIG, Maintained "Anavex Life Sciences Corp." (AVXL) at Strong Buy with Decreased Target from $35 to $28 on, Feb 9th, 2023.
Yun has made no other calls on AVXL in the last 4 months.
There is 1 other peer that has a rating on AVXL. Out of the 1 peers that are also analyzing AVXL, all agrees with Yun's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Charles Duncan of "Cantor Fitzgerald" Downgraded from Buy to Hold and Decreased Target to $11 on, Tuesday, December 6th, 2022
Contributing Sources